Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

125 Press Releases
DateTitleCompany
11 Jun 12 Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE(TM) Trial Amgen
25 Apr 12 Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company Amgen
11 Apr 12 Amgen to Acquire Privately Held KAI Pharmaceuticals Amgen,
03 Apr 12 Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio Amgen
07 Mar 12 Schwartz Center Receives $500,000 Grant from the Amgen Foundation Amgen
05 Mar 12 Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period Amgen
29 Feb 12 Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers Amgen
24 Feb 12 Amgen to Present at the Citi 2012 Global Healthcare Conference Amgen,
Published by
PharmiWeb.com
20 Sep 11 Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment Amgen,
Published by
PharmiWeb.com
24 Aug 11 Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application Amgen,
Published by
PharmiWeb.com
03 Aug 11 Xgeva®? (denosumab) granted marketing authorisation in the EU AMGEN,
Published by
Amgen
24 Jun 11 Notice to Investors Regarding 2011 and 2015 Guidance AMGEN,
Published by
PR Newswire
19 May 11 Amgen Oncology Data to be Presented at ASCO Annual Meeting Amgen,
Published by
PharmiWeb.com
15 Apr 11 Amgen to Webcast 2011 Business Review Meeting on April 21 Amgen,
Published by
PharmiWeb.com
11 Apr 11 Amgen Establishes Commercial Operations in Brazil Amgen,
Published by
PharmiWeb.com
08 Apr 11 Amgen Establishes Commercial Operations in Brazil Amgen,
Published by
PR Newswire
14 Dec 10 Scottish Medicines Consortium recommends Prolia®?(denosumab) for the treatment of postmenopausal osteoporosis Amgen Limited and GlaxoSmithKline
11 Nov 10 PUBLISHED RESULTS SHOW DENOSUMAB SUPERIOR TO ZOMETA® IN DELAYING OR PREVENTING BONE COMPLICATIONS IN PATIENTS WITH BONE METASTASES FROM ADVANCED BREAST CANCER Amgen,
Published by
Reynold-MacKenzie
05 Nov 10 Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards Amgen,
Published by
PR Newswire
27 Oct 10 NICE issues final recommendation for Prolia®?(denosumab) for the treatment of post-menopausal osteoporosis Amgen and GlaxoSmithKline
11 Oct 10 Is the UK Reaching Breaking Point? Experts and patient groups highlight urgent need for improvement in the management of osteoporosis in the UK Amgen and GSK
12 Aug 10 Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial Amgen,
Published by
PharmiWeb.com
23 Jul 10 Amgen Appoints Ronald D. Sugar to the Company's Board of Directors Amgen,
Published by
PharmiWeb.com
16 Jul 10 Amgen Appoints Jonathan M. Peacock Executive Vice President and Chief Financial Officer Amgen,
Published by
PharmiWeb.com
28 May 10 Revolutionary new osteoporosis treatment approved today for use in the UK Amgen/GSK
28 May 10 Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union Amgen,
Published by
PR Newswire
30 Apr 10 Amgen to Present at the Deutsche Bank 35th Annual Healthcare Conference Amgen,
Published by
PharmiWeb.com
27 Apr 10 Amgen Appoints Robert A. Bradway President and Chief Operating Officer Amgen,
Published by
PharmiWeb.com
21 Apr 10 Chemotherapy-Induced Neutropenia Can Cause Additional Burden and Risk for Cancer Patients, Pan-European Survey Reveals Amgen and the European Oncology Nursing Society,
Published by
Reynolds-MacKenzie
19 Apr 10 Analysis of Vectibix(R) Study Using New Gene Technology Helps to Advance Prospects for Personalized Medicine Amgen,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.